Promoter Elements Regulate Cytoplasmic mRNA Decay  by Bregman, Almog et al.
Promoter Elements Regulate
Cytoplasmic mRNA Decay
Almog Bregman,1 Moran Avraham-Kelbert,1 Oren Barkai,1 Lea Duek,1 Adi Guterman,1 and Mordechai Choder1,*
1Department of Molecular Microbiology, Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa 31096, Israel
*Correspondence: choder@technion.ac.il
DOI 10.1016/j.cell.2011.12.005SUMMARY
Promoters are DNA elements that enable transcrip-
tion and its regulation by trans-acting factors. Here,
we demonstrate that yeast promoters can also
regulate mRNA decay after the mRNA leaves the
nucleus. A conventional yeast promoter consists of
a core element and an upstream activating sequence
(UAS). We find that changing UASs of a reporter gene
without altering the transcript sequence affects the
transcript’s decay kinetics. A short cis element, com-
prising two Rap1p-binding sites, and Rap1p itself,
are necessary and sufficient to induce enhanced
decay of the reporter mRNA. Furthermore, Rap1p
stimulates both the synthesis and the decay of a
specific population of endogenous mRNAs. We pro-
pose that Rap1p association with target promoter in
the nucleus affects the composition of the exported
mRNP, which in turn regulates mRNA decay in the
cytoplasm. Thus, promoters can play key roles in
determining mRNA levels and have the capacity to
coordinate rates of mRNA synthesis and decay.
INTRODUCTION
Promoters were originally defined as DNA cis-acting elements
that direct the initiation of transcription. The collective efforts of
numerous scientists have revealed that one key function of these
elements is to promote the assembly of RNA polymerases in the
correct location of the transcription units, at the right time, in
a manner compatible with productive transcription (Kornberg,
2007). More recent work has demonstrated that promoters can
affect the entire process of transcription, including capping,
splicing, and polyadenylation (see, for example, Komili and
Silver, 2008; Orphanides and Reinberg, 2002). In higher eukary-
otes, promoters that drive RNA polymerase II (Pol II) transcription
are highly complex. The yeast promoters are less complex and
can be divided into two basic elements: the core promoter and
the ‘‘upstream activating sequence’’ (UAS) (Guarente, 1988).
The core promoter encompasses the transcription start site
and recruits Pol II and the basal transcription apparatus. UASs
are analogous to enhancers in higher eukaryotes and basically
enhance or repress assembly of competent basal transcription
apparatus, thereby regulating transcription (Harbison et al.,C2004 and references therein). Usually, UASs contain several
cis-acting elements capable of binding trans-acting factors
(e.g., chromatin remodelers, transcription activators or repres-
sors, adapters) (Harbison et al., 2004).
For historical reasons, mRNA decay has been studied less
intensively than transcription (Coller and Parker, 2004; Liu and
Kiledjian, 2006; Parker and Song, 2004; Wilusz and Wilusz,
2004), although RNA turnover is no less complex or important
than RNA synthesis. Several mRNA decay mechanisms have
been characterized, both in the nucleus (mainly for quality
control) and in the cytoplasm (Coller and Parker, 2004; Garneau
et al., 2007). Our understanding of mRNA decay in the yeast
cytoplasm is based on a few model mRNAs (mainly MFA2 and
PGK1 mRNAs). Two major cytoplasmic decay pathways exist.
Both are initiated by shortening of the mRNA poly(A) tail. The
mRNA can then be exonucleolytically degraded by the exosome
from 30 to 50 or by the Xrn1p exonuclease from 50 to 30. The latter
pathway involves removal of the mRNA 50 cap (m(7)GpppN)
(Decker and Parker, 1993), which is a prerequisite stage for
Xrn1p activity (Coller and Parker, 2004; Larimer et al., 1992;
Parker and Song, 2004). Although most yeast mRNAs are
degraded by either or both of these pathways, the half-lives of
specific mRNAs vary widely, ranging from 3 min to more than
90 min (Wang et al., 2002). What determines the half-life of
a specific mRNA?Conventional wisdom holds that mRNAs carry
all of the necessary information for this, both in their sequence
and structure. This premise is supported by a wealth of data
(Clark et al., 2009; LaGrandeur and Parker, 1999; Leipuviene
and Theil, 2007; Parker and Jacobson, 1990). However, this
notion was challenged by our previous discovery that Pol II
can control the fate of its transcripts in the cytoplasm (Goler-
Baron et al., 2008; Harel-Sharvit et al., 2010). Provoked by these
discoveries, we further tested the notion that other components
of the transcription apparatus can affect the decay machineries.
Here, we show that the mRNA half-life can be controlled by a
UASwithin the promoter. The studied promoters affect themajor
decay pathway, executed by Xrn1p, and seem to affect also an
Xrn1p-independent pathway. In the cases presented here, the
promoters seem to be the major elements that determine the
decay rates of their transcripts. Moreover, a small cis-acting
element consisting of two Rap1p-binding sites is required and
sufficient to destabilize the transcript. Rap1p is a well-known
transcription activator of highly transcribed genes (5% of the
yeast genes). We found that depletion of Rap1p leads to the
stabilization of mRNAs whose synthesis is activated by this
protein. Thus, Rap1p plays a dual role in maintaining the levelell 147, 1473–1483, December 23, 2011 ª2011 Elsevier Inc. 1473
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A Figure 1. Reporter Genes Encode Identical mRNA
(A) Reporter constructs. The constructs are derivatives of
those reported by Li et al. (1999). We inserted an oligo(G)18
tract 30 bases downstream of the stop codon and 70
bases upstream of the 30 end (excluding the poly(A) tail).
The constructs are identical except for the nature of their
upstream activating sequence (UAS), located upstream of
the ACT1 core promoter that includes the TATA box
(designated ‘‘TATA’’). The nucleotide boundaries of the
RPL30 sequences are depicted above the constructs, and
those of the ACT1 sequences are depicted below the
constructs. The numbering is in reference to the translation
start codon.
(B) mRNA A and mRNA B have identical 30 ends. RNA
purified from cells carrying construct A or construct B, as
indicated, was hybridized with the indicated oligonu-
cleotide or with both oligonucleotide and oligo(dT) and
digested with RNase H, as described in Experimental
Procedures. The digests were resolved by polyacrylamide
gel electrophoresis, followed by electrotransfer and
hybridization with RPL30pG probe at 75C (see Figure S1).
Note that thedistancebetween thepositionof the50 endsof
oligonucleotide 1 and 2 alongRPL30pGmRNA is 21 bases.
(C) mRNA A and mRNA B have identical 50 ends. RNA
purified from WT cells lacking any plasmid or from rpl30D
cells carrying either construct A or construct B (providing
the essential RPL30), as indicated, was hybridized with
oligonucleotide oMC1299 and digested with RNase H.
The digests were analyzed as in (B), except that the probe
was designed to detect the 50 fragment.
See also Figure S1.of specificmRNAs.We propose that Rap1p represents a class of
factors, synthegradases, whose recruitment to promoters stim-
ulates (or represses) both mRNA synthesis and decay. We
conclude that promoters and their trans-acting factors can
play more complex roles in gene expression than previously
appreciated.
RESULTS
Identical mRNAs, Whose Synthesis Is Governed
by Different UASs, Are Differentially Degraded
in the Cytoplasm
Promoters promotemRNA synthesis. To determinewhether they
can also affect the decay kinetics of their transcripts, we com-
pared half-lives of mRNAs derived from two similar plasmids
that were constructed previously (Li et al., 1999). Each construct
contains theRPL30 transcription unit, including the 30 noncoding
region. Transcription from both constructs is governed by
the ACT1 TATA box (Figure 1A). One of our constructs
(‘‘construct A’’) contains the ACT1 UAS, and the other (‘‘con-1474 Cell 147, 1473–1483, December 23, 2011 ª2011 Elsevier Inc.struct B’’) contains the RPL30 UAS (see Fig-
ure 1A). These two UASs were selected
because the natural ACT1 and RPL30 mRNAs
are degraded with different kinetics (Wang
et al., 2002). The endogenous natural RPL30
was not deleted and served as an internal
control. To differentiate between the plasmid-
borne and the endogenous RPL30 transcripts,we introduced a tract of oligo(G)18 into the 3
0 noncoding
sequence of the plasmid-derived RPL30 genes. Because a
(G)18 tract serves as a barrier to exonuclease activity (Decker
and Parker, 1993; Vreken and Raue´, 1992), 50-to-30 mRNA
degradation generates a degradation intermediate fragment
that stretches from the oligo(G)18 tract to the 3
0 end (called
‘‘Fragment’’). Thus, insertion of the oligo(G)18 allowed us to dif-
ferentiate between the plasmid-borne and the endogenous tran-
scripts, as well as to evaluate the degradation efficiency and the
decay pathway involved (Cao and Parker, 2001). Utilizing the
oligo(G)18 as a tag, we used two specific probes and two hybrid-
ization programs to detect either the plasmid-derived transcript
or the endogenous transcript (Figure S1 available online).
In order to verify that the two constructs transcribe identical
transcripts, we mapped the 50 and 30 ends of their mRNAs. To
map the 30 end, we cleaved RPL30pG mRNA around the stop
codon by hybridizing it with a specific oligonucleotide followed
by digestion with RNase H (Muhlrad and Parker, 1992). The
poly(A) tail was similarly removed by including oligo(dT) in
the reaction (Cao and Parker, 2001; Lotan et al., 2005, 2007).
The digests were analyzed by PAGE northern, using ‘‘RPL30pG
probe’’ (see Figure S1) to light up the 30 end of the cleaved
mRNAs. As shown in Figure 1B, lanes 3 and 4, the 30 ends of
the studied mRNAs ran as smears due to the heterogeneity of
their tails. After removing the poly(A) tail, the 30 fragments comi-
grated as bands, indicating that the 30 ends are identical (Fig-
ure 1B, lanes 7 and 8). We used an additional oligonucleotide
that hybridizes downstream of the stop codon, immediately
upstream of the (G)18 tract. This resulted in shorter 30 fragments
that also comigrated (Figure 1B, lanes 11 and 12). Moreover,
polyacrylamide gel electrophoretic mobility of their Fragment
at 120 min posttranscriptional arrest, when the poly(A) tail was
naturally removed (Cao and Parker, 2001; Lotan et al., 2005,
2007), was identical (results not shown). Importantly, the
poly(A)-containing smears were similar (Figure 1B, lanes 3 and
4), suggesting that the length of their tails is identical. To map
the 50 end, we deleted the endogenous RPL30, leaving the
plasmid as the only source of the essential Rpl30p (normal prolif-
eration of this strain demonstrated that the plasmid-borne tran-
script encodes a functional protein). mRNA A and mRNA B
were cleaved near the 50 ends and analyzed by northern blotting.
As shown in Figure 1C, the 50 ends of the studied RPL30pG
mRNAs are identical. These ends are shorter than that of
the endogenous RPL30 mRNA (Figure 1C), indicating that the
50UTRs of the endogenous and plasmid-borne mRNAs are
different. This difference is probably due to the ACT1 TATA
box in the core promoter region of the constructs that is absent
in the promoter of the endogenous gene. Collectively, the
plasmid-borne transcripts have identical 50 and 30 ends, most
probably because the reporter genes contain identical TATA
boxes, ORFs, and 30 noncoding regions. Hence, the two
plasmid-borne mRNAs are identical.
We monitored mRNA decay after blocking transcription using
two different drugs, 1,10-phenanthroline or thiolutin. The former
drug is a metal chelator that most likely inhibits Pol II by seques-
tering Mg+2. Thiolutin is not a chelator (it can act in the presence
of 1 mM Cu+2; see Figures 5 and S5), and it acts by interacting
with Pol II (Tipper, 1973). Remarkably, the decay of the two iden-
tical transcripts exhibited different kinetics (Figures 2A, 2B, 2E,
and S2A–S2C). Consistently, accumulation of Fragment—indic-
ative of the decay efficiency (Cao and Parker, 2001; Decker and
Parker, 1993; Lotan et al., 2007; Vreken and Raue´, 1992) —was
different for the twomRNAs (Figure 2A; see Fragment panel). The
accumulation kinetics of Fragment is complex, as it is generated
by Xrn1p-mediated 50-to-30 degradation and is then further
degraded by the exosome from 30 to 50 (Anderson and Parker,
1998) (for mathematical simulation of Fragment accumulation,
see Cao and Parker [2001]). Nevertheless, the different accumu-
lation of Fragment in the two cases clearly illustrates the differ-
ence in the rate of mRNA decay. The level of Fragment relative
to the full-length mRNA was determined at steady state. The
relative level of Fragment was higher in the case of mRNA
encoded by construct B (designated herein ‘‘mRNA B’’) as
compared to mRNA encoded by construct A (designated herein
‘‘mRNA A’’) (Figure 2F). This can also be observed in the ‘‘time 0’’
lanes shown in Figure 2A and S2D. Thus, even in optimally prolif-
erating cells whose transcription proceeds normally, the effect of
the studied UASs on mRNA decay is evident.CThe northern blot membrane was deprobed and then probed
with ‘‘RPL30 (endogenous)’’ probe (see Figure S1). Evidently,
the endogenous RPL30 mRNA was degraded identically in
the cells expressing either of the two plasmids (Figures 2A
and 2C). We normalized the decay kinetics of the plasmid-borne
mRNA to that of the endogenous mRNA. The results, shown in
Figure 2D, clearly show that mRNA A (whose synthesis is driven
by ACT1 UAS) was degraded more slowly than endogenous
RPL30 mRNA (hence the gradual increase in the ratio between
the plasmid-borne and endogenous mRNA). In contrast, mRNA
B (whose synthesis is driven by RPL30UAS) was degraded simi-
larly, albeit not identically, to endogenous RPL30 mRNA. This
difference might be due to the different 50UTRs in mRNA B and
endogenous RPL30 mRNA (see Figure 1C) and/or the different
context of their promoters. The RPL30 core promoter, which
construct B lacks, might also affect the decay of the endogenous
RPL30 mRNA. Be that as it may, these results indicate that the
RPL30 UAS serves as a major, albeit not necessarily the sole,
element that determines RPL30 mRNA degradation. mRNA
levels were also normalized to the endogenous ACT1 mRNA,
whose decay is slower than that of RPL30 mRNA (Wang et al.,
2002). As shown in Figure 2E, mRNA A was degraded similarly,
albeit not identically, to that of ACT1 mRNA, whereas mRNA B
was degraded faster.
The RPL30 primary transcript contains an intron (see Fig-
ure 1). As shown in Figures S2D–S2F, the stability of the intron-
containing transcript is also dependent on the UAS. Specifically,
following transcription arrest, transcript B disappears faster than
transcript A. Disappearance of the intron-containing transcript
might be due to splicing or, as was shown for the ACT1 intron,
degradation in the cytoplasm (Hilleren and Parker, 2003), or
a combination of the two. In the case that the disappearance is
due to splicing, faster splicing that characterizes transcript B
should negatively affect the apparent disappearance of the
mature mRNA B (i.e., the actual decay of the mature mRNA is
faster than observed). Hence, there are two options; each
supports our model whereby the UAS regulates mRNA decay.
Either the promoter affects splicing, in which case the difference
in the decay rates between mRNA A and B is in fact larger than
observed; or the decay of the primary transcript is controlled
by the same UAS-dependent mechanism that degrades
the mature mRNA. Since the pre-mRNA disappearance is
slower in xrn1D (results not shown), the pre-mRNA is probably
degraded in the cytoplasm; we therefore suspect that the latter
possibility is more likely.
In yeast, cytoplasmic mRNA decay is executed mainly by two
major pathways, one mediated by the 50-to-30 exonuclease
Xrn1p and the other by 30-to-50 exonuclease—the exosome
(see Introduction). To determine which of the two major cyto-
plasmic decay pathways is responsible for the decay of the
examined mRNAs, we deleted XRN1 or SKI7, thereby com-
promising Xrn1p-mediated 50-to-30 degradation or exosome-
mediated 30-to-50 degradation, respectively. Deletion of SKI7,
the adaptor that links the SKI complex with the exosome and
is required for the exosome activity (Araki et al., 2001; van
Hoof et al., 2000), did not lead to detectable stabilization of either
mRNA A or mRNA B (data not shown). In contrast, deletion of
XRN1 compromised the decay of both mRNAs (Figure S3),ell 147, 1473–1483, December 23, 2011 ª2011 Elsevier Inc. 1475
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Figure 2. Upstream Activating Sequence Can Affect the Stability of the Resulting mRNA
(A) Decay of mRNAs derived from the two constructs exhibit different kinetics. Cells were harvested in midlog phase at the indicated time points following
transcriptional arrest by 1,10-phenanthroline. Decay kinetics was determined, as reported previously (Lotan et al., 2005), by monitoring mRNA levels at the
indicated time points postdrug addition using northern analysis. The same membrane was reacted sequentially with the probes that are indicated at the left.
RPL30pG transcript and its Fragment were detected using an oligo(C)-containing probe (see Figure S1). The membrane carrying construct A was exposed to
X-ray film longer than the other membrane. Pol III transcript SCR1 is shown to demonstrate equal loading; its intensity was used for normalization in (B). The right
panel is shown to demonstrate the probe specificity; it contains RNA taken from cells expressing construct A or cells carrying no plasmid (–). See also Figure S1B.
(B and C) Band intensities were quantified by PhosphorImager. The intensity at time 0 (before adding the drug) was defined as 100%, and the intensities at the
other time points were calculated relative to time 0. Results were plotted as a function of time postdrug addition. Error bars represent standard error of three
assays. Statistical analysis demonstrates significant differences in decay kinetics. The most significant differences were detected at 25min and later time points,
p(TR 250) < 0.0001 (B) (see Experimental Procedures). No significant differenceswere observed between endogenousRPL30mRNAs obtained from the different
strains (C).
(D) Results normalized to the endogenous RPL30 mRNA. The ratio at time 0 was arbitrarily defined as 1. Error bars represent standard error of three assays.
Statistical analysis demonstrates significant differences for these ratios at or following 450, p(TR 450) < 0.004.
(E) Results normalized to the endogenous ACT1 mRNA, as in (D).
(F) Steady-state level of Fragment illustrates the impact of the studied UASs on mRNA degradation during optimal proliferation (in the absence of any drug). RNA
samples extracted from optimally proliferating cells (in midlogarithmic phase) were loaded such that the intensity of the full-length mRNAs (designated
‘‘RPL30pG’’) would be comparable (left lanes) or that the intensity of mRNA A would be higher than that of mRNA B (right lanes).
See also Figure S2.indicating that both mRNAs are substrates of Xrn1p. Neverthe-
less, deletion of XRN1 affected more substantially the decay of
mRNA A than B. Consequently, mRNA B was not completely
stable in xrn1D cells (Figures 3D, S3A, and S3B), indicating
that an Xrn1p-independent mechanism also contributes to its
degradation. This suggests that UASs can also affect the
30-to-50 decay pathway (or as yet undefined mechanism). It
seems that the exosome effect on the decay of these mRNAs
is either too weak to be observed or that it does not require
Ski7p. Because Xrn1p is mainly a cytoplasmic protein (Johnson,
1997; Sheth and Parker, 2003), we conclude that the degrada-
tion of both mRNAs occurs in the cytoplasm. Indeed, these
mRNAs are mainly cytoplasmic, as most of them are associated
with polysomes (data not shown). Collectively, our results
indicate that UASs can regulate the Xrn1p-dependent and inde-
pendent cytoplasmic mRNA decay pathways. Consistently,
differential decay is observed in both ski7D and xrn1D cells (Fig-
ure 3). Note that, although the error bars in Figure 3D are large,1476 Cell 147, 1473–1483, December 23, 2011 ª2011 Elsevier Inc.statistical analysis indicated that the decay kinetics of the two
mRNAs is nevertheless significantly different (p < 0.0004). The
differential decay kinetics observed in both xrn1D and ski7D
strains indicate that no single pathway is fully responsible for
these differences.
As shown in Figure S3C, lanes 1–6, accumulation of Fragment
in ski7D cells was correlated with the progression of mRNA B
degradation. This result is interpreted to indicate that the degra-
dation of every full-length mRNA gave rise to a relatively stable
Fragment, designated herein Fragment B. Fragment stability
was probably due to defective exosome activity. In contrast,
the Fragment derived from mRNA F (whose transcription is gov-
erned by RapBS-lacking promoter), designated Fragment F,
accumulated to a lesser degree during the time course of the
experiment (Figure S3C, lanes 7–12). This result is consistent
with the poor decay of mRNA F. Alternatively, the relatively small
accumulation of Fragment F is due to its faster degradation
relative to Fragment B. Both of these possibilities support our
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Figure 3. Differential Decay of mRNA A and mRNA B Is Maintained in Both ski7D and xrn1D Cells
(A and B) Decay kinetics of mRNAs encoded by construct A or B, expressed in ski7D strain, isogenic to the strain used in Figures 2, 3, and 4, was determined as
described in Figures 2A and 2B.
(C and D) Decay kinetics of mRNAs encoded by construct A or B, expressed in xrn1D strain, isogenic to the strain used in Figures 2, 3, and 4, was determined as
described in Figures 2A and 2B.
See also Figure S3.premise that mRNA B and mRNA F, which are identical (data
not shown), are degraded at a different pace or by different
mechanisms.
Rap1p-Binding Sites Are Necessary and Sufficient
to Confer Enhanced mRNA Decay
Like other promoters of genes encoding ribosomal proteins,
the RPL30 promoter contains several cis-acting elements
(Li et al., 1999). To determine which UAS element is responsible
for the mRNA decay, we analyzed the stability of transcripts
whose transcription is controlled by truncated promoters lacking
different portions of theRPL30UAS. As shown in Figures 4B–4D,
deleting most of the RPL30 UAS but leaving the two Rap1-
binding sites (RapBS) intact had little effect on the transcript
stability, as both the decay kinetics of the full-length mRNA
and the relative level of Fragment were very similar. These results
raise the possibility that RapBS is responsible for the transcript’s
rapid decay.
RapBS is a well-studied element found in 90% of ribosomal
protein (RP) promoters (see Discussion). To determine whether
RapBS is both required and sufficient to confer the characteristic
short half-life, we deleted it from RPL30 UAS in ‘‘construct B’’
and inserted it into the ACT1UAS of ‘‘construct A,’’ thus creating
constructs F and E, respectively (Figure 4E), which encode
mRNAs that are identical to mRNA A and B (data not shown).CRemarkably, surgical removal of RapBS from the RPL30 UAS
stabilized the transcript, whereas its insertion into the ACT1
UAS destabilized the transcript (Figures 4F and 4G, respec-
tively). Thus, in the context of theRPL30 andACT1UASs, RapBS
has a dominant effect on mRNA decay.
To examine the effect of RapBS on the degradation status of
the studied mRNAs in optimally proliferating cells, we deter-
mined accumulation of Fragment at steady-state conditions.
As shown in Figure 4H, the presence of RapBS is associated
with a relatively high Fragment level. This result demonstrates
the capacity of RapBS to modulate mRNA decay in the cytosol
under optimal conditions. Note that this assay does not involve
any drug or any particular cell treatment.
To examine the effect of the promoter context on the capacity
of RapBS to affect mRNA decay, mRNA levels transcribed
by constructs A, B, E, and F were analyzed, using three-way
ANOVA statistical analysis (see statistical analysis in Experi-
mental Procedures). As shown in Figure S4, mRNAs derived
from constructs A and F, lacking RapBS, had similar decay
kinetics, and both were relatively stable. Moreover, mRNAs
derived from constructs B and E, which harbor RapBS, had
similar decay kinetics, exhibiting faster decay. Thus, the pres-
ence of RapBS is correlated with enhanced mRNA decay,
irrespective of the other promoter elements. We then asked
whether other promoter elements contribute to mRNA decay.ell 147, 1473–1483, December 23, 2011 ª2011 Elsevier Inc. 1477
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Figure 4. RPL30 RapBS Is Required and Sufficient for Maintaining the Characteristic Enhanced Decay Rate of RPL30pG mRNA
(A) Constructs used in (B)–(D). Construct B is described in Figure 1A. Construct C is identical to B except that the T-rich domain was deleted. Construct D lacks the
entire UAS except for the RapBS (Li et al., 1999). Symbol key is as in Figure 1A.
(B) Decay kinetics of the indicated mRNAs was performed and quantified as in Figure 2B.
(C) Levels of the endogenous RPL30 as a function of time posttranscriptional arrest.
(D) Results of RPL30pG mRNA levels normalized to the endogenous mRNA were calculated as in Figure 2D. Error bars in all panels represent standard error of
three assays. No significant differences were found between the behaviors of the three samples in any of the assays.
(E-H) Removal of RapBS from RPL30 UAS stabilizes the RPL30pG mRNA, whereas its insertion in ACT1 UAS destabilizes the transcript.
(E) Constructs E and F are derivatives of constructs A and B (see Figure 1), created by site-directedmutagenesis (see Experimental Procedures). The symbols key
is as in Figure 1A.
(F and G) Decay kinetics of the indicated mRNAs was determined as described in Figure 2B.
(H) The impact of RapBS on the relative level of Fragment. Assay was performed as in Figure 2F. Different exposure durations of the samemembranewere used to
demonstrate the relative intensities of the full-length mRNAs (short) and that of Fragment (medium and long).
See also Figure S4.Statistical analysis indicated that the interaction between
RapBS and other promoter sequences (i.e., all other sequences
except for the RapBS) was not significant. Therefore, we
analyzed each factor independently. By so doing, we revealed
that the presence or absence of RapBS in any of the two
promoters was sufficient to confer significant differences on
mRNA decay kinetics, p(TR 150) < 0.0001 (see statistical anal-
ysis in Experimental Procedures). The same statistical analysis
also indicated that the two promoter sequences (PACT1/
PRPL30), independently of RapBS, have significant differences,
though smaller, on mRNA decay kinetics, p(T R 250) < 0.002.
Thus, the three-way ANOVA analysis demonstrates that
the effect of RapBS on mRNA decay is independent of the con-
text of the two studied promoters. Nevertheless, UAS elements
other than RapBS have additional effect, albeit a more
modest one.1478 Cell 147, 1473–1483, December 23, 2011 ª2011 Elsevier Inc.Rap1p Is Both mRNA Synthetic and a Decay Factor
The effect of RapBS on mRNA decay suggests that Rap1p is
involved in determining the mRNA decay pathway and/or
kinetics. Rap1p is an essential protein. Therefore, we transiently
depleted it without affecting cell viability. To this end,weutilized a
Cu2+-modulated expression shutoff system (‘‘Copper-degron’’)
(Moqtaderi et al., 1996). A control strain and Cu2+-depletable
Rap1p strain (Pardo and Marcand, 2005) were treated with
CuSO4 for 3 hr (see efficacy and time course of Rap1p depletion
in Figure S5A) and then with Thiolutin to block transcription.
As expected, decay kinetics of mRNAs of control (WT) cells
revealed differential decay of mRNA A and mRNA B (Figure 5B,
cf left and right panel). Remarkably, this differential decay was
diminished upon depletion of Rap1p due to increased mRNA B
stability (Figure 5B, right). Depletion of Rap1p did not abolish
the effect of RapBS completely, suggesting that either the
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Figure 5. Depletion of Rap1p Specifically Compromises Degradation of mRNAs Whose Synthesis Is Activated by Rap1p
(A) Depletion of Rap1p affects degradation kinetics of mRNA B. Cells were treated with CuSO4, as described in Figure S5A, for 3 hr. Thiolutin (3 mM) was then
added and decay kinetics determined as in Figure 2A.
(B) Band intensities were quantified as in Figure 2B (normalized toSCR1 transcript). Error bars represent standard error of three assays. p value was calculated as
in Figure 2B. ‘‘Rap1p’’ denotes Rap1p depletion.
(C) Steady-state level of the indicatedmRNA. The level inWT strain was arbitrarily defined as 100%. Error bars represent standard error of six assays. The p value
forACT1UASpanel was insignificant (0.3). The p value forRPL30UASpanel wasmarginal (0.08); however, becausemRNABbecomes stable as a result of Rap1p
depletion, we conclude that transcription was downregulated after Rap1p depletion.
(D–I) Decay kinetics of the indicated endogenous mRNAs. Assays were performed as in (A), (B), and (C). The p value for (F) is < 0.0001 and for (I) is 0.72.
See also Figure S5.residual Rap1p was still effective or that RapBS affects mRNA
decay by an additional Rap1p-independent mechanism. Signifi-
cantly, Rap1p depletion affected the decay of the endogenous
RPL30 mRNA (Figures 5D and 5E), as well as that of RPL5
mRNA (Figures S5B and S5C) and NSR1 (data not shown), but
not that of YEF3 mRNA (Figures 5G and 5H). As indicated by
steady-state mRNA levels and taking into account the mRNA
stability, Rap1p stimulated transcription of RPL30 (Figure 5F),
RPL5 (Figure S5D), andNSR1 (data not shown) but did not affect
transcription of YEF3 (Figure 5I). Rap1p-stimulated mRNA
synthesis and decay is correlated with the presence of RapBS
in the affected genes (Lieb et al., 2001). Thus, Rap1p is required
for enhanceddegradation ofmRNABaswell as efficient decay of
mRNAs whose transcription is regulated by Rap1p. Collectively,
the capacity of Rap1p to stimulate mRNA synthesis and decay isCdependent on the presence of RapBS in the UAS, a feature that
reflects natural genes whose promoters contain RapBS.
Summarily, our results indicate that Rap1p is both an mRNA
synthetic and degradation factor. The capacity of Rap1p to acti-
vate mRNA synthesis and decay is dependent on the presence
of RapBS in the promoters.
DISCUSSION
Promoters Can Regulate mRNA Decay in the Cytoplasm
Although recent studies have revealed that consecutive stages
of gene expression are coupled (Komili and Silver, 2008),
conventional wisdom holds that, after its release from the Pol
II, the fate of the mRNA in the cytoplasm is unaffected by the
promoter. In the present study, we demonstrate that this viewell 147, 1473–1483, December 23, 2011 ª2011 Elsevier Inc. 1479
is oversimplified and that promoter elements can affect mRNA
decay in the yeast cytoplasm. Specifically, RPL30 UAS con-
ferred a short half-life on the reporter mRNA, similar to the
half-life of the endogenous RPL30 mRNA. In contrast, ACT1
UAS conferred a longer half-life on an identical reporter mRNA,
similar to that of the endogenousACT1mRNA (Figure 2). An early
study revealed that the steady-state level of a premature stop
codon-containing b-globin is influenced by the nature of its
promoter, raising the possibility that the promoter can regulate
mRNA decay in humans as well (Enssle et al., 1993).
We note that some of our results might be consistent with the
possibility that the drugs we used here repress transcription in
a differential manner, depending on the presence or absence
of RapBS. Several observations argue against it. First, experi-
ments performed with two different drugs that repress Pol II by
different mechanisms (one is metal chelator and the other acts
by interacting with Pol II) yielded similar results. Second, the rela-
tive Fragment level, which is indicative of the decay status (Cao
and Parker, 2001), was affected by RapBS (Figures 2F, 4H, S2D,
and S3C;). Third, XRN1 deletion affected differentially the decay
of mRNA A and B (Figures S3A and S3B). Fourth, accumulation
of Fragment, which became relatively stable due to SKI7 dele-
tion, was inconsistent with identical decay of mRNA B and F
and their Fragments (see discussion of Figure S3C in Results).
The role of the promoter in mRNA decay broadens our view of
the crosstalk between the synthetic and decay machineries that
operate in different compartments. We propose that the tran-
scripts are not exported to the cytoplasm as ‘‘independent’’ enti-
ties. They are marked, or imprinted, with some tags that later
control their fate (Choder, 2011). The nature of this tag can vary.
Thus, the transcript can be imprinted by tagging it with an addi-
tionalRNAorRNPmolecule (e.g., throughbasepairing). Imprinting
can also involve a protein, or a complex of proteins such as the
exon-exon junction complex, or certain components of the RNA
cleavage and polyadenylation complex. Alternatively, the pro-
moter can recruit a factor that acts catalytically without leaving
the promoter. This factor can thenmodify some specific transcript
bases or the transcript structure, thereby affecting the transcript
function and/or its fate at later stages (Choder, 2011). The length
of the poly(A) tail or its associated factors (e.g., the number of
Pab1p molecules) can also serve as tags. In the case presented
here, however, the poly(A) tails of the studied mRNAs were very
similar; hence, the tail length does not seem to play an important
role.Adocumentedcaseof tagging is thecotranscriptionalbinding
of Rpb4/7, an mRNA coordinator (for definition of mRNA coordi-
nator, see Harel-Sharvit et al., 2010), with the emerging Pol II
transcripts (Goler-Baron et al., 2008; Harel-Sharvit et al., 2010).
The extent of mRNA imprinting by Rpb4/7 can be subject to
regulation, thereby regulatingmRNAdecay after themRNA leaves
the nucleus (Shalem et al., 2011). We hypothesize that promoters
can contribute to the cotranscriptional imprinting of mRNAs,
similar to the contribution of Pol II-mediated imprinting (Choder,
2011). The nature of this tagging remains to be determined.
Rap1-Binding Sites Impact the Cytoplasmic mRNA
Decay
Systematic dissection of the RPL30 UAS uncovered RapBS as
an element that is required and sufficient to confer short half-1480 Cell 147, 1473–1483, December 23, 2011 ª2011 Elsevier Inc.life. Furthermore, RapBS can dominantly destabilize the reporter
mRNA if placed in ACT1 UAS (Figure 4). RapBS is found in
telomeres as well as in 5% of Pol II promoters. Approximately
90% of ribosomal protein (RP) promoters contain predicted
RapBSs (Lascaris et al., 1999; Warner, 1999). Rap1p is bound
to essentially all such RP promoters in vivo (Lieb et al., 2001;
Schawalder et al., 2004) and is involved in their transcription acti-
vation (Lieb et al., 2001 and references therein).
RapBS is highly variable. The only indisputable feature for
all RapBSs is that they harbor an extended sequence of
12—14 bp (Pin˜a et al., 2003). Interestingly, Rap1p function is
modulated by the precise architecture of its binding site and
its surroundings. It was therefore proposed that Rap1p alters
its structure to bind to different versions of its DNA binding
sequence (Pin˜a et al., 2003). Evidently, Rap1 is a rather unusual
factor whose activity is dependent on context. It can function as
an activator or repressor, can affect chromatin architecture, and
can enhance Pol II pausing (Pelechano et al., 2009). This latter
function is also context specific, as it characterizes only RP
genes. It seems that Rap1p plays unique roles in RP promoters.
We propose that the Rap1p-RapBS complex affects imprinting
of mRNAs encoding RP by recruiting (a) certain protein(s) to
the promoter. The recruited protein(s) bind(s) the transcript
cotranscriptionally and later regulate(s) its demise, similar to
the function assigned to Rpb4/7 (Goler-Baron et al., 2008;
Harel-Sharvit et al., 2010).
The observation that promoter elements can have such
a strong impact on mRNA decay was unexpected. At least in
the case of RPL30, the two RapBSs were responsible, to a great
extent, for the characteristic decay kinetics of the endogenous
mRNAs (Figures 2D and 4D). This observation suggests that,
in some cases, the most important decisions regarding the
transcript stability are already made during transcription in the
nucleus. This model challenges a common view that the cyto-
plasmic decay factors regulate mRNA decay in the cytoplasm
(Coller and Parker, 2004; Liu and Kiledjian, 2006; Parker and
Song, 2004; Wilusz and Wilusz, 2004). On the other end of the
spectrum, our results also call for re-evaluating previous results
that relied on mRNA levels as a means to study the transcrip-
tional activities of promoters and promoter elements.
Importantly, the promoter does not seem to play a major role
in the decay of all mRNAs. For example, replacing PGK1
30UTR with MFA2 30UTR led to enhanced decay of the chimeric
mRNA relative to that of PGK1 mRNA (LaGrandeur and Parker,
1999). It is possible that MFA2 30UTR is an independent
cis-acting RNA element with the capacity to stimulate mRNA
decay (although the effect of changing RNA cis elements
was determined by manipulating the DNA, which encodes the
element, and the possible impact of the DNA was not ruled
out). We suspect that mRNA decay rates are regulated by
a combination of nuclear and cytoplasmic processes and that
the relative contribution of each compartment varies between
the genes and/or between environmental conditions.
Synthegradases: Factors that Act on Both mRNA
Synthetic and Decay Machineries
A common theme is now emerging whereby some transcription
activators (e.g., Rap1p, Rpb4/7, Ccr4p) enhance mRNA decay.
We propose to name these factors ‘‘synthegradases’’ to empha-
size their dual role. Recent studies demonstrated that environ-
mentally induced genes are subject to transcriptional induction
that is accompanied by an increase in decay rate of their tran-
scripts (Elkon et al., 2010; Molin et al., 2009; Rabani et al.,
2011; Shalem et al., 2008). This counterintuitive ‘‘counter-
action’’ characterizes mainly mRNAs whose levels are shaped
by a sharp ‘‘peaked’’ behavior (Rabani et al., 2011; Shalem
et al., 2008). The capacity of the synthegradases, like Rap1p,
to enhance both mRNA synthesis and decay might serve as
a mechanistic basis for this phenomenon. As proposed previ-
ously, the combination of enhanced synthesis and decay permits
rapid acquisition of a new steady-state level (Shalem et al.,
2008). We suspect that the two-arms mechanism of the synthe-
gradases is more responsive to regulatory signals. Specifically,
signaling pathways can modulate either the synthetic or the
decay function of the synthegradases, thereby fine-tuning the
desired steady-state levels, as well as the kinetics with which
they are achieved.
Recent comparison between mRNA decay kinetics in two
related Saccharomyces species revealed a significant difference
in 11% of the orthologous mRNAs. In half of these cases, the
different decay was coupled to a difference in transcription.
Coupling almost always involves enhancement of both mRNA
synthesis and decay or, conversely, repression of both mRNA
synthesis and decay (Dori-Bachash et al., 2011). Moreover,
some yeast factors (most notably Rpb4p and Ccr4p) seem to
have evolved in a manner that either enhances both mRNA
synthesis and decay or represses both activities simultaneously.
At least 5% of the 3,000 yeast genes examined in this study (that
excludes genes encoding ribosomal proteins) is likely to be regu-
lated by synthegradases during optimal proliferation conditions
(Dori-Bachash et al., 2011). We suspect that this number is likely
to increase upon shifts from optimal to stress conditions and
after including the Rap1p-regulated genes. A corollary of the
double roles of promoters and synthegradases has evolutionary
implications, whereby a single mutation in either a promoter or
a synthegradase can affect both mRNA synthesis and decay,
which otherwise would require two independent mutations (see
also Dahan et al., 2011).
Concluding Remarks
Previous work has uncovered intricate linkages between
the various stages of the mRNA life cycle (recently reviewed in
Dahan et al., 2011). Such linkages can better regulate the ratio
between signal and noise; they can play pivotal roles during
the adaptation to a new environmental condition by regulating
the proper dynamics in obtaining new mRNA levels and their
proper translation (Dahan et al., 2011). Our results show that
promoters can contribute to the interplay between mRNA syn-
thesis and decay. We propose that some promoters can coordi-
nate between the two processes that determine the steady-
state mRNA level and play a key role in shaping the kinetic of
obtaining new levels in response to the environment. It would
be very interesting to examine whether the dialog between
the synthetic and decay machineries is bilateral, whereby
mRNA decay machineries affect the transcriptional function of
promoters.CEXPERIMENTAL PROCEDURES
Yeast Strains and Growth
The BY4741 yeast strain (Euroscarf) (MATa, his3D1, leu2D0, met15D0,
ura3D0) and its xrn1D or ski7D derivatives were grown at 30C in batch
cultures with shaking at 200 rpm, using selective synthetic medium. ZMY60
(MATa, ura3-52, trp1-D1, ade2-101 pACE1-UBR1, pACE1-ROX1) (Moqtaderi
et al., 1996) and lev391 (MATa, ura3-52, trp1-D1, ade2-101, pACE1-UBR1,
pACE1-ROX1 rap1-(D)::KAN R (KANR-ANB-UBI-R-lacI-4HA-RAP1) (Pardo
and Marcand, 2005) were transformed with construct A or construct B and
were grown in a selectivemedium at 30C as above. When the culture reached
53 106 cells/ml, CuSO4 (1mM)was added and the cultures were shaken for an
additional 3 hr before Thiolutin was added. yBA57–yBA60 are rpl30 D haploid
derivatives of BY4743 (Mat a/a; his3D1/his3D1; leu2D0/leu2D0; lys2D0/LYS2;
MET15/met15D0; ura3D0/ura3D0; rpl30D::kanMX4/RPL30) that express the
various constructs as the only source of RPL30.
Site-Directed Mutagenesis
Insertion of (G)18 tract, as well as insertion or deletion of RapBS, was
performed using the Muta-Gene M13 in vitro Mutagenesis kit (Bio-Rad).
RNA Cleavage by RNase H
Site-specific cleavage of mRNA A and B was performed basically as
described previously (Muhlrad and Parker, 1992). In brief, deoxyoligonucleo-
tides were designed as follows. oMC1296 (designated in Figure 1B as ‘‘1’’)
is 50-TTACCTTATTTAAGCCAAGG-30; oMC1297 (designated in Figure 1B
as ‘‘2’’) is 50-CTTCCAACAAATCG-30; oMC1299 (used in Figure 1C) is
50-CCTAAGGTGTACTTACC-30. RNA (12 mg) was mixed with 300 ng of the
respective oligonucleotide and dried in a speed vac, and the pellet was resus-
pended in 10 ml of 25 mM Tris (pH 7.5), 1 mM EDTA, and 50 mM NaCl. The
mixture was heated at 68C for 10 min and cooled slowly to 30C at room
temperature. RNase H digestion was performed as described (Muhlrad and
Parker, 1992). The tubes were incubated at 30C for 50 min and 15 min at
37C. RNA was extracted by phenol/chloroform followed by ethanol precipi-
tation. The pellet was dissolved in 80% formamide and 10 mM EDTA and
dyes. The cleaved RNA (5 mg) was electrophoresed in 6% PAGE for 2.5 hr
at 300 V in TBE buffer followed by electrotransfer onto GeneScreen plus
membrane.
Determining mRNA Levels and mRNA Degradation Profile
A cell aliquot from the culture was taken for time 0 and then treated
with 100 mM of 1,10-phenanthroline (Merk) or 3 mM of Thiolutin (Pfizer).
Cell harvesting, RNA extraction, and northern analysis were performed as
described previously (Lotan et al., 2005). Polyacrylamide northern analysis
(Sachs and Davis, 1989) was performed as described previously (Lotan
et al., 2005).
Statistical Analysis
In most cases, two-way analysis of variance (ANOVA) was performed, using
‘‘Fit Model’’ of JMP7 statistical program to analyze the mRNA levels. The
factors that were used in the model were: (1) yeast strains that differ in the
construct they contain (Construct), (2) time points of cell harvest (Time),
and (3) the interaction between these factors (Construct*Time). Factor with
p(F) < 0.05 was considered significant. When interaction was found to be
significant, mRNA levels were compared in each time point using F test in
the slice option of the software (equivalent to t test). We concluded that there
are significant differences in the decay kinetics when the p(F) for a given time
point was significant, and the significance was larger at the later time points. In
the figures, we indicated the p(F) for the first time point that exhibits a highly
significant value. Note that, in all of our experiments, the significance was
larger at the later time points. In Figure S4, the levels of RPL30pG mRNAs
derived from constructs A, B, E, and F were divided into two factors: (1)
Rap1p-binding sites (presence/absence) and (2) all promoter sequences other
than Rap1p-binding site (PACT1/ PRPL30), leading to three-way ANOVA. In the
cases of Figures 5 (C, F, and I) and S5D, the differences in the steady-state
levels were analyzed by t test.ell 147, 1473–1483, December 23, 2011 ª2011 Elsevier Inc. 1481
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